🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combined chemotherapy consisting of endovenous Nabpaclitaxel-Gemcitabine an...
Status
Unknown
Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Start Date
2022-03-01
Trial ID
NCT05371223
Induction mFOLFIRINOX has become the standard in the management of locally ...
Status
Recruiting
Location
CHU de Rouen
Start Date
2025-12-08
Trial ID
NCT07044453
Treatments Being Tested
This was an open-label, single-arm, multi-center, Phase II study to determi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-07-02
Trial ID
NCT00709761
Treatments Being Tested
Studies H0648g and M77001 confirmed that the combination of trastuzumab wit...
Status
Unknown
Location
Multiple Locations
Start Date
2022-12-10
Trial ID
NCT05621434
Treatments Being Tested
The goal of this platform clinical trial is to test how well novel treatmen...
Status
Active Not Recruiting
Location
Arizona Oncology Associates,Substudy-02
Start Date
2023-03-16
Trial ID
NCT05633667
Retrospective, multicenter study including pts with metastatic pancreatic c...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-01
Trial ID
NCT03620461
Treatments Being Tested
Background: LMB-100 is a man-made protein designed to kill cancer cells. L...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-08-03
Trial ID
NCT02810418
Treatments Being Tested
The purpose of Part 1 of this First-in-Human trial is to evaluate the safet...
Status
Completed
Location
Centro Ricerche Cliniche di Verona srl
Start Date
2021-06-28
Trial ID
NCT05027568
Treatments Being Tested
The purpose of the first part of this study or the dose escalation portion ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02117817
Treatments Being Tested
This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast act...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2025-10-28
Trial ID
NCT07377045
Treatments Being Tested